Your browser doesn't support javascript.
loading
Molecular testing practices and perceptions among dermatopathologists.
Torre, Kristin; Jhorar, Preeti; Wu, Rong; Pfeifer, John; Elaba, Zendee; Murphy, Michael.
Afiliación
  • Torre K; University of Connecticut School of Medicine, Farmington, Connecticut.
  • Jhorar P; Department of Dermatology, UConn Health, Farmington, Connecticut.
  • Wu R; The Biostatistics Center, Connecticut Institute for Clinical and Translational Science, Farmington, Connecticut.
  • Pfeifer J; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
  • Elaba Z; Department of Pathology, Hartford Hospital, Hartford, Connecticut.
  • Murphy M; University of Connecticut School of Medicine, Farmington, Connecticut.
J Cutan Pathol ; 45(6): 387-394, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29436726
BACKGROUND: We evaluated how dermatopathologists are employing molecular testing in the setting of neoplastic skin diseases, and assessed their opinions of the broader role and utility of molecular technologies in clinical practice. METHODS: A 15-question online survey was sent to Fellows of the American Society of Dermatopathology in April 2017. RESULTS: One hundred and thirty-six dermatopathologists completed the survey (response rate = 16%). A majority (94%) of respondents reported experience with one or more molecular testing strategies. Sixty-two percent of dermatopathologists order 12 or more molecular tests per year, while 5% of respondents order 2 or fewer assays per year. More frequent utilization of molecular testing is associated with relevant instruction during residency training (P = .009), primary board certification in pathology (P = .008), academic medical center affiliation (P = <.0001), higher volume clinical practice (P = .0004), presence of on-site clinical molecular pathology/cytogenetics laboratory (P = .007), and greater physician confidence incorporating test results into histopathological assessments (P = <.0001). CONCLUSIONS: Wider adoption of molecular testing in dermatopathology may be limited by factors such as physician training, test costs/insurance coverage, logistical issues and lack of evidence-based clinical practice guidelines. Dermatopathologists have concerns regarding clinical validity/utility and inappropriate/overuse of some molecular tests. The importance of longitudinal education in molecular technologies and their applications for trainee and practicing physicians is highlighted.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Pautas de la Práctica en Medicina / Conocimientos, Actitudes y Práctica en Salud / Medicina Molecular / Dermatólogos / Patólogos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cutan Pathol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Pautas de la Práctica en Medicina / Conocimientos, Actitudes y Práctica en Salud / Medicina Molecular / Dermatólogos / Patólogos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cutan Pathol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos